BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Argus Health
Express Scripts
Fish and Richardson

Generated: September 23, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Midol Liquid Gels, and what generic Midol Liquid Gels alternatives are available?

Midol Liquid Gels is a drug marketed by Bionpharma Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in MIDOL LIQUID GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for Tradename: MIDOL LIQUID GELS

Suppliers / Packagers: see list1
Clinical Trials: see list1,016
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MIDOL LIQUID GELS at DailyMed
Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Bionpharma Inc
CAPSULE;ORAL021472-001Oct 18, 2002OTCYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MIDOL LIQUID GELS

Country Document Number Estimated Expiration
European Patent Office1207872► Subscribe
Canada2382292► Subscribe
Australia780212► Subscribe
Poland362850► Subscribe
Japan2003508434► Subscribe
Austria357229► Subscribe
World Intellectual Property Organization (WIPO)0115688► Subscribe
Germany60034044► Subscribe
Australia7094900► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus